Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.
Contractor K, Challapalli A, Barwick T, Winkler M, Hellawell G, Hazell S, Tomasi G, Al-Nahhas A, Mapelli P, Kenny LM, Tadrous P, Coombes RC, Aboagye EO, Mangar S. Contractor K, et al. Among authors: aboagye eo. Clin Cancer Res. 2011 Dec 15;17(24):7673-83. doi: 10.1158/1078-0432.CCR-11-2048. Epub 2011 Oct 28. Clin Cancer Res. 2011. PMID: 22038995
3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.
Challapalli A, Barwick T, Pearson RA, Merchant S, Mauri F, Howell EC, Sumpter K, Maxwell RJ, Aboagye EO, Sharma R. Challapalli A, et al. Among authors: aboagye eo. Eur J Nucl Med Mol Imaging. 2015 May;42(6):831-40. doi: 10.1007/s00259-015-3000-2. Epub 2015 Feb 12. Eur J Nucl Med Mol Imaging. 2015. PMID: 25673055
Evaluation of 18F-fluorothymidine positron emission tomography ([18F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer.
Sharma R, Mapelli P, Hanna GB, Goldin R, Power D, Al-Nahhas A, Merchant S, Ramaswami R, Challapalli A, Barwick T, Aboagye EO. Sharma R, et al. Among authors: aboagye eo. EJNMMI Res. 2016 Dec;6(1):81. doi: 10.1186/s13550-016-0234-3. Epub 2016 Nov 16. EJNMMI Res. 2016. PMID: 27854031 Free PMC article.
Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patients.
Arshad MA, Thornton A, Lu H, Tam H, Wallitt K, Rodgers N, Scarsbrook A, McDermott G, Cook GJ, Landau D, Chua S, O'Connor R, Dickson J, Power DA, Barwick TD, Rockall A, Aboagye EO. Arshad MA, et al. Among authors: aboagye eo. Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):455-466. doi: 10.1007/s00259-018-4139-4. Epub 2018 Sep 1. Eur J Nucl Med Mol Imaging. 2019. PMID: 30173391 Free PMC article.
[18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer.
Sharma R, Valls PO, Inglese M, Dubash S, Chen M, Gabra H, Montes A, Challapalli A, Arshad M, Tharakan G, Chambers E, Cole T, Lozano-Kuehne JP, Barwick TD, Aboagye EO. Sharma R, et al. Among authors: aboagye eo. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1239-1251. doi: 10.1007/s00259-019-04532-z. Epub 2019 Nov 21. Eur J Nucl Med Mol Imaging. 2020. PMID: 31754793 Free PMC article. Clinical Trial.
Clinical translation of 18F-fluoropivalate - a PET tracer for imaging short-chain fatty acid metabolism: safety, biodistribution, and dosimetry in fed and fasted healthy volunteers.
Dubash SR, Keat N, Kozlowski K, Barnes C, Allott L, Brickute D, Hill S, Huiban M, Barwick TD, Kenny L, Aboagye EO. Dubash SR, et al. Among authors: aboagye eo. Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2549-2561. doi: 10.1007/s00259-020-04724-y. Epub 2020 Mar 2. Eur J Nucl Med Mol Imaging. 2020. PMID: 32123971 Free PMC article.
277 results